A novel mRNA binding protein complex promotes localized plasminogen activator inhibitor-1 accumulation at the myoendothelial junction.
نویسندگان
چکیده
OBJECTIVE Plasminogen activator inhibitor-1 (PAI-1) has previously been shown to be key to the formation of myoendothelial junctions (MEJs) in normal and pathological states (eg, obesity). We therefore sought to identify the mechanism whereby PAI-1 could be selectively accumulated at the MEJ. METHODS AND RESULTS We identified PAI-1 protein enrichment at the MEJ in obese mice and in response to tumor necrosis factor (TNF-α) with a vascular cell coculture. However, PAI-1 mRNA was also found at the MEJ and transfection with a PAI-1-GFP with TNF-α did not demonstrate trafficking of the protein to the MEJ. We therefore hypothesized the PAI-1 mRNA was being locally translated and identified serpine binding protein-1, which stabilizes PAI-1 mRNA, as being enriched in obese mice and after treatment with TNF-α, whereas Staufen, which degrades PAI-1 mRNA, was absent in obese mice and after TNF-α application. We identified nicotinamide phosphoribosyl transferase as a serpine binding protein-1 binding partner with a functional τ-like microtubule binding domain. Application of peptides against the microtubule binding domain significantly decreased the number of MEJs and the amount of PAI-1 at the MEJ. CONCLUSIONS We conclude that PAI-1 can be locally translated at the MEJ as a result of a unique mRNA binding protein complex.
منابع مشابه
mrNa Binding Protein Complex Promotes Localized Plasminogen activator inhibitor-1 accumulation at the Myoendothelial Junction
The myoendothelial junction (MEJ) is a heterocellular junction located predominantly within the resistance vasculature and comprises vascular smooth muscle cells (VSMCs) and endothelial cell (EC) extensions that extend from each cell type into the internal elastic lamina and form a close apposition with the opposing cell membrane. The MEJ is presumed to be a highly organized signaling microdoma...
متن کاملCellular Biology Plasminogen Activator Inhibitor-1 Regulates Myoendothelial Junction Formation
متن کامل
Hepatocyte growth factor regulates E box-dependent plasminogen activator inhibitor type 1 gene expression in HepG2 liver cells.
OBJECTIVE We sought to determine the etiologic mechanism of pleiotropic growth factor, hepatocyte growth factor (HGF), as a regulator of hepatic synthesis of plasminogen activator inhibitor (PAI)-1, the physiological inhibitor of fibrinolysis and a potential inducer of atherothrombosis. METHODS AND RESULTS HGF increased PAI-1 mRNA expression and PAI-1 protein accumulation in the conditioned m...
متن کاملInhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif.
Plasminogen activator inhibitor-2 (PAI-2) is well documented as an inhibitor of the extracellular serine proteinase urokinase-type plasminogen activator (uPA) and is expressed in activated monocytes and macrophages, differentiating keratinocytes, and many tumors. Here we show that PAI-2 has a novel intracellular function as a retinoblastoma protein (Rb)-binding protein. PAI-2 colocalized with R...
متن کاملRegulation of myoendothelial junction formation: bridging the gap.
In this issue of Circulation Research, Heberlein et al1 provide exciting new insight into the actions of plasminogen activator (PA) inhibitor (PAI)-1 by illuminating its role in governing the ability of endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) to communicate with each other through specialized contacts defined as myoendothelial junctions (MEJs). In the resistance vascula...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Arteriosclerosis, thrombosis, and vascular biology
دوره 32 5 شماره
صفحات -
تاریخ انتشار 2012